Lv61
2820 积分 2024-12-14 加入
The molecular landscape of head and neck cancer
6小时前
待确认
G9a/GLP Modulators: Inhibitors to Degraders
17天前
已完结
The next generation of antibody–drug conjugates
30天前
已完结
Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma
2个月前
已完结
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
3个月前
已完结
The Epigenetic Hallmarks of Cancer
3个月前
已完结
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
3个月前
已完结
Untangling the ErbB signalling network
4个月前
已完结
Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
4个月前
已完结
Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation
4个月前
已完结
皖公网安备34019202002308
